PuraPharm Corp Ltd

Detailed Description

PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mailand China, and internationally. The company operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. It offers holistic products under the PuraGold, Haveron, CardioClear, PuraPharm Lingzhi, and Arashi Kuni names; and various therapeutic products under the Nong's, Oncozac, and Immuzac names for Chinese medicine practitioners. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules (CCMG) products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it researches, develops, and trades in modernized Chinese medicines; and provides Chinese medical diagnostic services. The company sells its products to hospitals, medical institutions, and medicine practitioners, as well as operates an online store. As of December 31, 2019, the company operated 67 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.